EUVIMEDEUVIMED entdecken
Übersichtsarbeit

EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy

Shaheen Ali, Anam Ilyas, Shagufi Nazar, Mukund Jha, Vishal Mathur, Sana Tanweer, Sonam Grover, Ozair Alam

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04596-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Shaheen Ali und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, School of Interdisciplinary Sciences and Technology, Jamia Hamdard, New Delhi, 110062, India. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 131 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsNeoplasmsAntineoplastic AgentsHumansErbB ReceptorsAnimalsDrug Resistance, NeoplasmNanoparticlesDrug Delivery SystemsMolecular Targeted TherapyTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

EGFRNanoparticleOncologyTKTK Inhibitors

Substanzen

Protein Kinase InhibitorsErbB ReceptorsAntineoplastic AgentsEGFR protein, humanTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Molecular Medicine, School of Interdisciplinary Sciences and Technology, Jamia Hamdard, New Delhi, 110062, India.
  • Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
  • Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. oalam@jamiahamdard.ac.in.

Zitieren

APA

Ali, S., Ilyas, A., Nazar, S., Jha, M., Mathur, V., Tanweer, S., Grover, S., & Alam, O. (2026). EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04596-9

Vancouver

Ali S, Ilyas A, Nazar S, Jha M, Mathur V, Tanweer S, et al. EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04596-9

BibTeX
@article{Ali2026,
  author = {Ali, Shaheen and Ilyas, Anam and Nazar, Shagufi and Jha, Mukund and Mathur, Vishal and Tanweer, Sana and Grover, Sonam and Alam, Ozair},
  title = {EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04596-9}
}
Kostenlos starten →